Filter Results:
(237)
Show Results For
- All HBS Web
(1,722)
- Faculty Publications (237)
Show Results For
- All HBS Web
(1,722)
- Faculty Publications (237)
←
Page 12 of 237
Results
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one... View Details
Keywords: Information Technology; Organizational Structure; Technological Innovation; Business Processes; Health Care and Treatment; Performance Productivity; Welfare; Agribusiness; Genetics; Science-Based Business; Biotechnology Industry; Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details
Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Pharmaceutical Industry; Biotechnology Industry; Switzerland; Europe
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono." Harvard Business School Case 396-035, September 1995.
- February 1994 (Revised May 1999)
- Case
Manville Corp. Fiber Glass Group (C)
By: Lynn S. Paine and Sarah Gant
Manville Corp.'s senior managers are surprised when Japanese government officials advise them not to go forward with their plan to add a cancer warning label to diatomaceous earth (DE) products sold in Japan. The International Agency for Research on Cancer has ruled... View Details
Keywords: Management Teams; Ethics; Conflict of Interests; Health; Safety; Cross-Cultural and Cross-Border Issues; Policy; Japan
Paine, Lynn S., and Sarah Gant. "Manville Corp. Fiber Glass Group (C)." Harvard Business School Case 394-116, February 1994. (Revised May 1999.)
- March 1993
- Supplement
Burroughs Wellcome and AZT (B)
Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details
Keywords: Ethics; Health Pandemics; Multinational Firms and Management; Price; Crime and Corruption; Risk and Uncertainty; Business Strategy; Business and Community Relations; Business and Government Relations; Business and Shareholder Relations; Pharmaceutical Industry
Emmons, Willis M., III. "Burroughs Wellcome and AZT (B)." Harvard Business School Supplement 793-114, March 1993.
- March 1993
- Supplement
Burroughs Wellcome and AZT (C)
Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details
Keywords: Health Pandemics; Multinational Firms and Management; Financial Statements; Pharmaceutical Industry; United States
Emmons, Willis M., III. "Burroughs Wellcome and AZT (C)." Harvard Business School Supplement 793-115, March 1993.
- February 1993 (Revised March 1995)
- Case
Bernd Sterzel at the IVth Medizinische Klinik (A)
By: Linda A. Hill
After 10 years of running a small laboratory at Yale Medical School, Dr. R. Bernd Sterzel assumes leadership of a nephrology clinic in Nurnberg and Erlangen, Germany. In his ambitious efforts to transform the clinic into a leading academic research institution, he... View Details
Keywords: Change Management; Organizational Change and Adaptation; Problems and Challenges; Cross-Cultural and Cross-Border Issues; Health Industry; Germany; Connecticut
Hill, Linda A. "Bernd Sterzel at the IVth Medizinische Klinik (A)." Harvard Business School Case 493-059, February 1993. (Revised March 1995.)
- June 1991 (Revised June 1993)
- Case
Becton Dickinson (B): Global Management
By: Michael Beer
The president of Becton Dickinson (BD) and his top management team struggle with issues of: 1) how to manage the top of the organization, focusing on leadership style, the committee structure, and the role of sector presidents, and 2) how to manage a multinational... View Details
Keywords: Globalized Firms and Management; Multinational Firms and Management; Human Resources; Leadership Style; Management Teams; Corporate Strategy; Health Industry
Beer, Michael. "Becton Dickinson (B): Global Management." Harvard Business School Case 491-152, June 1991. (Revised June 1993.)
- April 1989 (Revised January 1994)
- Case
Novo Industri
By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details
Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry
Porter, Michael E., and Michael J. Enright. "Novo Industri." Harvard Business School Case 389-148, April 1989. (Revised January 1994.)
- September 1984 (Revised September 1993)
- Case
Nestle S.A.: International Marketing (A)
By: John A. Quelch
A senior manager at Nestle's headquarters is reviewing the role of the central marketing staff with respect to Nestle's operating companies around the world. Two specific examples of the role of the central staff in guiding the advertising and packaging decisions of... View Details
Keywords: Globalized Firms and Management; Organizational Design; Organizational Structure; Marketing; Operations; Advertising; Management Teams; Health Industry; Health Industry; Switzerland
Quelch, John A., and Edward J. Hoff. "Nestle S.A.: International Marketing (A)." Harvard Business School Case 585-013, September 1984. (Revised September 1993.)
- 1979
- Book
Global Malnutrition and Cereal Fortification
By: James E. Austin
Austin, James E., ed. Global Malnutrition and Cereal Fortification. Cambridge, MA: Ballinger Publishing Company, 1979.
- Teaching Interest
Business Opportunties in Climate Adaptation
By: John D. Macomber
This is a Short Intensive Program or SIP at Harvard Business School. It’s an optional student offering prior to the formal start of the Spring semester the following week. SIPs tend to cover new material on current topics, to be less formal than the HBS Case Study... View Details
- Research Summary
Evolution of the Global Beauty Industry
This research examines the global beauty industry, which includes cosmetics, deodorants, fragrances, hair care, oral hygiene and skin care. Today global sales of cosmetics and toiletries are in excess of U.S. $380 billion. This research examines the growth of this... View Details
- Teaching Interest
Managing Health Care Delivery - Executive Education
While delivering patient care has always been a primary goal of health care organizations, financial outcomes have long been the metric by which success is measured. Increasingly, however, health care leaders are being held accountable for... View Details
- Teaching Interest
Overview
Course Requirements
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
Students are required to prepare a business plan, which employs the framework of this course, to explore an entrepreneurial opportunity in health care, and to evaluate their classmates' plans.
Career Focus
For... View Details
- Research Summary
Overview
By: Robert S. Kaplan
Kaplan introduced time-driven activity-based costing (TDABC) to provide the cost component in Michael Porter's Value Based Health Care framework of delivering superior patient outcomes at lower societal cost. TDABC is becoming the global standard for health care... View Details
- Research Summary
Overview
By: William C. Kirby
A historian by training, Professor Kirby examines contemporary China's business, economic, and political development in an international context. He writes and teaches on the growth of modern companies in China (Chinese and foreign; state-owned and private); Chinese... View Details
Keywords: China; Internationalization; Educational Policy And Politics; Infrastructure; Government And Business; The Revival Of Family Business In China; China’s Infrastructure Exports: The ‘Belt And Road’ Initiative; Agribusiness; Education; Entrepreneurship; Globalization; Governance; Government and Politics; History; Philanthropy and Charitable Giving; Social Enterprise; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; Asia; Europe; North and Central America
- ←
- 12